March 8, 2024Open Access

Individualized High Dose Intravenous Anakinra Treatment in Cancer Patients with COVID-19 Associated Cytokine Storm: A Retrospective Controlled Study

Key Points

Key points are not available for this paper at this time.

Abstract

Coronavirus disease 2019 (COVID-19) is a potentially life-threatening disease caused by SARS-CoV-2. Clinical findings of COVID-19 are ranged from asymptomatic to severe pneumoniae, acute respiratory distress syndrome, multiorgan failure and death. A severe COVID-19 course is associated with a higher inflammatory state (cytokine storm) due to the excessive release (...)

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Çakmak et al. (Fri,) studied this question.

synapsesocial.com/papers/68e752dab6db6435876cb856 https://doi.org/https://doi.org/10.36519/idcm.2024.287

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Predictors of Mortality in Severe and Critical COVID-19 Patients Receiving High Dose Intravenous Anakinra2023 · 1 citations
2The COVID-19 Cytokine Storm; What We Know So Far2020 · 1,698 citations
3IL-1 pathways in inflammation and human diseases2010 · 901 citations
4Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis2020 · 650 citations
5Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis2020 · 3,772 citations

Bookmark

View Full Paper